Advertisement
Screener

Caribou Biosciences, Inc. (CRBU) ROA

Caribou Biosciences, Inc. (CRBU) ROA

  • 2026-06-30: ROA -72.42%.
  • 2026-03-31: ROA -89.41%.
  • 2025-12-31: ROA -84.47%.
  • 2025-09-30: ROA -80.58%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-72.42%
2026-03-31-89.41%
2025-12-31-84.47%
2025-09-30-80.58%
2025-06-30-74.36%
2025-03-31-54.03%
2024-12-31-47.59%
2024-09-30-43.02%
2024-06-30-33.10%
2024-03-31-28.33%
2023-12-31-23.62%
2023-09-30-20.67%
2023-06-30-31.80%
2023-03-31-31.19%
2022-12-31-26.60%
2022-09-30-22.79%
2022-06-30-20.23%
2022-03-31-16.33%
2021-12-31-15.13%
2021-09-30-13.67%
2021-06-30-31.63%
2020-12-31-95.18%

Annual ROA

DateROA
2025-12-31-84.47%
2024-12-31-47.59%
2023-12-31-23.62%
2022-12-31-26.60%
2021-12-31-15.13%
2020-12-31-95.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22